
HLS Therapeutics Inc
TSX:HLS

Gross Margin
HLS Therapeutics Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
CA |
![]() |
HLS Therapeutics Inc
TSX:HLS
|
154.9m CAD |
83%
|
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
89B USD |
4%
|
|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
56.5B USD |
3%
|
|
US |
![]() |
Cencora Inc
NYSE:COR
|
56.3B USD |
3%
|
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
37.6B USD |
4%
|
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
32.8B AUD |
7%
|
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
75B CNY |
33%
|
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
70.4B CNY |
11%
|
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
30%
|
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD |
32%
|
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
13%
|
HLS Therapeutics Inc
Glance View
HLS Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Etobicoke, Ontario and currently employs 92 full-time employees. The firm is focused on developing clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. Its products include Vascepa, Trinomia, Clozaril, CSAN Pronto, PERSERIS and MyCare Psychiatry/MyCare Insite. Its lead product, Clozaril, is an atypical antipsychotic indicated in the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules reduce the risk of cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or hospitalization for unstable angina in statin-treated patients with elevated triglycerides.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on HLS Therapeutics Inc's most recent financial statements, the company has Gross Margin of 83.1%.